These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 6277381)

  • 21. Antiviral potential of phosphonoacetic acid.
    Overby LR; Duff RG; Mao JC
    Ann N Y Acad Sci; 1977 Mar; 284():310-20. PubMed ID: 212978
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of reverse transcriptase activity of avian myeloblastosis virus by pyrophosphate analogues.
    Eriksson B; Stening G; Oberg B
    Antiviral Res; 1982 May; 2(1-2):81-95. PubMed ID: 6179470
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Herpes simplex virus DNA polymerase as the site of phosphonoacetate sensitivity: temperature-sensitive mutants.
    Purifoy DJ; Powell KL
    J Virol; 1977 Nov; 24(2):470-7. PubMed ID: 199734
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of cytomegalovirus late antigens by phosphonoformate.
    Wahren B; Oberg B
    Intervirology; 1980; 12(6):335-9. PubMed ID: 6244238
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mode of inhibition of herpes simplex virus DNA polymerase by phosphonoacetate.
    Mao JC; Robishaw EE
    Biochemistry; 1975 Dec; 14(25):5475-9. PubMed ID: 53071
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential incorporation of thymidylate analogues into DNA by DNA polymerase alpha and by DNA polymerases specified by two herpes simplex viruses.
    Kowalzick L; Gauri KK; Spadari S; Pedrali-Noy G; Kühne J; Koch G
    J Gen Virol; 1982 Sep; 62 (Pt 1)():29-38. PubMed ID: 6290594
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Amino acid changes within conserved region III of the herpes simplex virus and human cytomegalovirus DNA polymerases confer resistance to 4-oxo-dihydroquinolines, a novel class of herpesvirus antiviral agents.
    Thomsen DR; Oien NL; Hopkins TA; Knechtel ML; Brideau RJ; Wathen MW; Homa FL
    J Virol; 2003 Feb; 77(3):1868-76. PubMed ID: 12525621
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structure-activity studies on phosphonoacetate.
    Mao JC; Otis ER; von Esch AM; Herrin TR; Fairgrieve JS; Shipkowitz NL; Duff RG
    Antimicrob Agents Chemother; 1985 Feb; 27(2):197-202. PubMed ID: 2984985
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of herpesvirus and human DNA polymerases by alpha-halogenated phosphonoacetates.
    McKenna CE; Khawli LA; Bapat A; Harutunian V; Cheng YC
    Biochem Pharmacol; 1987 Oct; 36(19):3103-6. PubMed ID: 3663227
    [No Abstract]   [Full Text] [Related]  

  • 30. Isolation of a herpesvirus-specific DNA polymerase from tissues of an American patient with Burkitt lymphoma.
    Allaudeen HS; Bertino JR
    Proc Natl Acad Sci U S A; 1978 Sep; 75(9):4504-8. PubMed ID: 212756
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative study of herpes group virus-induced DNA polymerases.
    Mar EC; Huang ES
    Intervirology; 1979; 12(2):73-83. PubMed ID: 231586
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Carbonyldiphosphonate, a selective inhibitor of mammalian DNA polymerase delta.
    Talanian RV; Brown NC; McKenna CE; Ye TG; Levy JN; Wright GE
    Biochemistry; 1989 Oct; 28(21):8270-4. PubMed ID: 2557899
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased efficacy of phosphonoformate and phosphonoacetate inhibition of herpes simplex virus type 2 replication by encapsulation in liposomes.
    Szoka FC; Chu CJ
    Antimicrob Agents Chemother; 1988 Jun; 32(6):858-64. PubMed ID: 2843083
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis of esters of phosphonoformic acid and their antiherpes activity.
    Norén JO; Helgstrand E; Johansson NG; Misiorny A; Stening G
    J Med Chem; 1983 Feb; 26(2):264-70. PubMed ID: 6298425
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Incorporation of the carbocyclic analog of 2'-deoxyguanosine into the DNA of herpes simplex virus and of HEp-2 cells infected with herpes simplex virus.
    Parker WB; Shaddix SC; Allan PW; Arnett G; Rose LM; Shannon WM; Shealy YF; Montgomery JA; Secrist JA; Bennett LL
    Mol Pharmacol; 1992 Feb; 41(2):245-51. PubMed ID: 1311407
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reversible inhibition of cytomegalovirus replication by phosphonoformate.
    Wahren B; Oberg B
    Intervirology; 1980; 14(1):7-15. PubMed ID: 6259084
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Selective inhibition of herpes simplex virus type 1 DNA polymerase by zinc ions.
    Fridlender B; Chejanovsky N; Becker Y
    Virology; 1978 Feb; 84(2):551-4. PubMed ID: 203099
    [No Abstract]   [Full Text] [Related]  

  • 38. Genetic evidence for vaccinia virus-encoded DNA polymerase: isolation of phosphonoacetate-resistant enzyme from the cytoplasm of cells infected with mutant virus.
    Moss B; Cooper N
    J Virol; 1982 Aug; 43(2):673-8. PubMed ID: 7109036
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Isolation and characterization of phosphonoacetic acid-resistant mutants of human cytomegalovirus.
    D'Aquila RT; Summers WC
    J Virol; 1987 Apr; 61(4):1291-5. PubMed ID: 3029427
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of HIV-1 RNA-dependent DNA polymerase and cellular DNA polymerases alpha, beta and gamma by phosphonoformic acid and other drugs.
    Wondrak EM; Löwer J; Kurth R
    J Antimicrob Chemother; 1988 Feb; 21(2):151-61. PubMed ID: 2452149
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.